LKFT
As of 2026-09-07, Lakefront Biotherapeutics NV (LKFT) has a market capitalization of $1.88 B, making it the #2193 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $1.88 B |
| 2026-09-06 | $1.88 B |
| 2026-09-05 | $1.88 B |
| 2026-09-04 | $1.88 B |
| 2026-09-03 | $1.91 B |
| 2026-09-02 | $1.90 B |
| 2026-09-01 | $1.88 B |
| 2026-08-31 | $1.88 B |
| 2026-08-30 | $1.90 B |
| 2026-08-29 | $1.90 B |
| 2026-08-28 | $1.90 B |
| 2026-08-27 | $1.94 B |
As of 2026-09-07, Lakefront Biotherapeutics NV (LKFT) has a market capitalization of $1.88 B, making it the #2193 most valuable US-listed company.
Lakefront Biotherapeutics NV is the #2193 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $1.93 B |
| 2026-08-25 | $1.96 B |
| 2026-08-24 | $1.90 B |
| 2026-08-23 | $1.90 B |
| 2026-08-22 | $1.90 B |
| 2026-08-21 | $1.90 B |
| 2026-08-20 | $1.86 B |
| 2026-08-19 | $1.93 B |
| 2026-08-18 | $1.84 B |
| 2026-08-17 | $1.81 B |
| 2026-08-16 | $1.81 B |
| 2026-08-15 | $1.81 B |
| 2026-08-14 | $1.81 B |
| 2026-08-13 | $1.85 B |
| 2026-08-12 | $1.84 B |
| 2026-08-11 | $1.87 B |
| 2026-08-10 | $1.77 B |
| 2026-08-09 | $1.78 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.